These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

128 related articles for article (PubMed ID: 38677634)

  • 1. A machine learning algorithm improves the diagnostic accuracy of the histologic component of antibody mediated rejection (AMR-H) in cardiac transplant endomyocardial biopsies.
    Glass M; Ji Z; Davis R; Pavlisko EN; DiBernardo L; Carney J; Fishbein G; Luthringer D; Miller D; Mitchell R; Larsen B; Butt Y; Bois M; Maleszewski J; Halushka M; Seidman M; Lin CY; Buja M; Stone J; Dov D; Carin L; Glass C
    Cardiovasc Pathol; 2024; 72():107646. PubMed ID: 38677634
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Reclassification of C4d-Positive Endomyocardial Biopsy (EMB) According to New International Society for Heart and Lung Transplantation (ISHLT) 2013 Categories for Reporting Pathologic Antibody-Mediated Rejection (pAMR): Preliminary Data from a Polish Single-Center Study.
    Szymańska S; Grajkowska W; Sobieszczańska-Małek M; Zieliński T; Pronicki M
    Ann Transplant; 2015 Jun; 20():351-6. PubMed ID: 26101425
    [TBL] [Abstract][Full Text] [Related]  

  • 3. CD68/CD31 immunohistochemistry double stain demonstrates increased accuracy in diagnosing pathologic antibody-mediated rejection in cardiac transplant patients.
    Glass C; Butt YM; Gokaslan ST; Torrealba JR
    Am J Transplant; 2019 Nov; 19(11):3149-3154. PubMed ID: 31339651
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Inflammatory cell burden and phenotype in endomyocardial biopsies with antibody-mediated rejection (AMR): a multicenter pilot study from the AECVP.
    Fedrigo M; Leone O; Burke MM; Rice A; Toquet C; Vernerey D; Frigo AC; Guillemain R; Pattier S; Smith J; Lota A; Potena L; Bontadini A; Ceccarelli C; Poli F; Feltrin G; Gerosa G; Manzan E; Thiene G; Bruneval P; Angelini A; Duong Van Huyen JP
    Am J Transplant; 2015 Feb; 15(2):526-34. PubMed ID: 25612500
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Biopsy-diagnosed antibody-mediated rejection based on the proposed International Society for Heart and Lung Transplantation working formulation is associated with adverse cardiovascular outcomes after pediatric heart transplant.
    Everitt MD; Hammond ME; Snow GL; Stehlik J; Revelo MP; Miller DV; Kaza AK; Budge D; Alharethi R; Molina KM; Kfoury AG
    J Heart Lung Transplant; 2012 Jul; 31(7):686-93. PubMed ID: 22551931
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Upregulation of Endothelial HLA Class II is a Marker of Antibody-Mediated Rejection in Heart Allograft Biopsies.
    Cai Q; Moore SA; Hendricks AR; Torrealba JR
    Transplant Proc; 2020 May; 52(4):1192-1197. PubMed ID: 32197864
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Correlations of lymphocyte subset infiltrates with donor-specific antibodies and acute antibody-mediated rejection in endomyocardial biopsies.
    Frank R; Dean SA; Molina MR; Kamoun M; Lal P
    Cardiovasc Pathol; 2015; 24(3):168-72. PubMed ID: 25440957
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Phosphorylated S6 kinase and S6 ribosomal protein are diagnostic markers of antibody-mediated rejection in heart allografts.
    Li F; Wei J; Valenzuela NM; Lai C; Zhang Q; Gjertson D; Fishbein MC; Kobashigawa JA; Deng M; Reed EF
    J Heart Lung Transplant; 2015 Apr; 34(4):580-587. PubMed ID: 25511749
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Pathologic classification of antibody-mediated rejection correlates with donor-specific antibodies and endothelial cell activation.
    Tible M; Loupy A; Vernerey D; Suberbielle C; Beuscart T; Cazes A; Guillemain R; Amrein C; Pezzella V; Fabiani JN; Nochy D; Hill G; Empana JP; Jouven X; Charron D; Bruneval P; Duong Van Huyen JP
    J Heart Lung Transplant; 2013 Aug; 32(8):769-76. PubMed ID: 23856214
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A web-based pilot study of inter-pathologist reproducibility using the ISHLT 2004 working formulation for biopsy diagnosis of cardiac allograft rejection: the European experience.
    Angelini A; Andersen CB; Bartoloni G; Black F; Bishop P; Doran H; Fedrigo M; Fries JW; Goddard M; Goebel H; Neil D; Leone O; Marzullo A; Ortmann M; Paraf F; Rotman S; Turhan N; Bruneval P; Frigo AC; Grigoletto F; Gasparetto A; Mencarelli R; Thiene G; Burke M
    J Heart Lung Transplant; 2011 Nov; 30(11):1214-20. PubMed ID: 21816625
    [TBL] [Abstract][Full Text] [Related]  

  • 11. ISHLT pathology antibody mediated rejection score correlates with increased risk of cardiovascular mortality: A retrospective validation analysis.
    Hammond MEH; Revelo MP; Miller DV; Snow GL; Budge D; Stehlik J; Molina KM; Selzman CH; Drakos SG; Rami A A; Nativi-Nicolau JN; Reid BB; Kfoury AG
    J Heart Lung Transplant; 2016 Mar; 35(3):320-325. PubMed ID: 26970471
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Role of morphologic parameters on endomyocardial biopsy to detect sub-clinical antibody-mediated rejection in heart transplantation.
    Fedrigo M; Gambino A; Benazzi E; Poli F; Frigo AC; Tona F; Caforio AL; Castellani C; Toscano G; Feltrin G; Gerosa G; Thiene G; Angelini A
    J Heart Lung Transplant; 2011 Dec; 30(12):1381-8. PubMed ID: 21930398
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Deep learning-enabled classification of kidney allograft rejection on whole slide histopathologic images.
    Ye Y; Xia L; Yang S; Luo Y; Tang Z; Li Y; Han L; Xie H; Ren Y; Na N
    Front Immunol; 2024; 15():1438247. PubMed ID: 39034991
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Time-dependent specificity of immunopathologic (C4d-CD68) and histologic criteria of antibody-mediated rejection for donor-specific antibodies and allograft dysfunction in heart transplantation.
    Yerly P; Rotman S; Nobile A; Aubert V; Tozzi P; Yarol N; Vogt P; Hullin R; Pascual M
    Transplantation; 2015 Mar; 99(3):586-93. PubMed ID: 24983305
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Donor-specific anti-HLA antibodies with antibody-mediated rejection and long-term outcomes following heart transplantation.
    Clerkin KJ; Farr MA; Restaino SW; Zorn E; Latif F; Vasilescu ER; Marboe CC; Colombo PC; Mancini DM
    J Heart Lung Transplant; 2017 May; 36(5):540-545. PubMed ID: 27916323
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Gene Expression Profiling for the Identification and Classification of Antibody-Mediated Heart Rejection.
    Loupy A; Duong Van Huyen JP; Hidalgo L; Reeve J; Racapé M; Aubert O; Venner JM; Falmuski K; Bories MC; Beuscart T; Guillemain R; François A; Pattier S; Toquet C; Gay A; Rouvier P; Varnous S; Leprince P; Empana JP; Lefaucheur C; Bruneval P; Jouven X; Halloran PF
    Circulation; 2017 Mar; 135(10):917-935. PubMed ID: 28148598
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Utility of routine immunofluorescence staining for C4d in cardiac transplant recipients.
    Gupta S; Mitchell JD; Lavingia B; Ewing GE; Feliciano MN; Kaiser PA; Ring WS; Stastny P; Patel PC; Markham DW; Mammen PP; Dimaio JM; Drazner MH
    J Heart Lung Transplant; 2009 Aug; 28(8):776-80. PubMed ID: 19632572
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Acute Cellular Rejection and C4d Positivity in Heart Transplantation : A Manifestation of Asymptomatic Antibody-Mediated Rejection?
    Mohamedali B; Pyle J; Bhat G
    Am J Clin Pathol; 2016 Feb; 145(2):238-43. PubMed ID: 26767383
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Digital pathology evaluation of complement C4d component deposition in the kidney allograft biopsies is a useful tool to improve reproducibility of the scoring.
    Brazdziute E; Laurinavicius A
    Diagn Pathol; 2011 Mar; 6 Suppl 1(Suppl 1):S5. PubMed ID: 21489200
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Longitudinal evaluation of microvessel density in survivors vs. nonsurvivors of cardiac pathologic antibody-mediated rejection.
    Revelo MP; Miller DV; Stehlik J; Brunisholz K; Drakos S; Gilbert EM; Everitt M; Budge D; Alharethi R; Snow G; Hammond EH; Kfoury AG
    Cardiovasc Pathol; 2012; 21(6):445-54. PubMed ID: 22381397
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.